ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas

Autor: Aliyeva, S, Wilder-Smith, A, Preet, R, Brickley, EB, de Alencar Ximenes, RA, de Barros Miranda-Filho, D, Martelli, CMT, de Araújo, TVB, Montarroyos, UR, Moreira, ME, Turchi, MD, Solomon, T, Jacobs, BC, Villamizar, CP, Osorio, L, de Filipps, AMB, Neyts, J, Kaptein, S, Huits, R, Ariën, KK, Willison, HJ, Edgar, JM, Barnett, SC, Peeling, R, Boeras, D, Guzman, MG, de Silva, AM, Falconar, AK, Romero-Vivas, C, Gaunt, MW, Sette, A, Weiskopf, D, Lambrechts, L, Dolk, H, Morris, JK, Orioli, LM, O'Reilly, KM, Yakob, L, Rocklöv, J, Soares, C, Ferreira, MLB, de Oliveira Franca, RF, Precioso, AR, Logan, J, Lang, T, Jamieson, N, Massad, E

Publikováno v: Global Health Action
Global Health Action, 2019, 12 (1), pp.1666566. ⟨10.1080/16549716.2019.1666566⟩
Global Health Action, Vol 12, Iss 1 (2019)
Global Health Action, 12(1):1666566. Taylor & Francis Ltd

Zika Preparedness Latin American Network (ZikaPLAN) is a research consortium funded by the European Commission to address the research gaps in combating Zika and to establish a sustainable network with research capacity building in the Americas. Here

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f08fda6e4412b53b2e698e73a1afc32c
https://hal-pasteur.archives-ouvertes.fr/pasteur-04057542

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.

Autor: Etienne I; Chest Department, Hôpital Universitaire de Bruxelles Erasme, Université Libre de Bruxelles, Brussels, Belgium; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: isabelle.etienne@hubruxelles.be., Kemlin D; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium; Department of Nephrology, Dialysis and Transplantation, Hôpital Universitaire de Bruxelles Erasme, Université Libre de Bruxelles, Brussels, Belgium., Gemander N; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium; Department of Nephrology, Dialysis and Transplantation, Hôpital Universitaire de Bruxelles Erasme, Université Libre de Bruxelles, Brussels, Belgium., Olislagers V; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium., Waegemans A; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium., Dhondt E; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Heyndrickx L; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Depickère S; Plateform Interventional Studies, Scientific Direction Infectious Diseases in Humans, Sciensano, Brussels, Belgium., Charles A; Plateform Interventional Studies, Scientific Direction Infectious Diseases in Humans, Sciensano, Brussels, Belgium., Goossens M; Plateform Interventional Studies, Scientific Direction Infectious Diseases in Humans, Sciensano, Brussels, Belgium., Vandermosten L; Laboratory of Immune Response, Scientific Direction Infectious Diseases in Humans, Sciensano, Brussels, Belgium., Desombere I; Laboratory of Immune Response, Scientific Direction Infectious Diseases in Humans, Sciensano, Brussels, Belgium., Ariën KK; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Pannus P; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium., Knoop C; Chest Department, Hôpital Universitaire de Bruxelles Erasme, Université Libre de Bruxelles, Brussels, Belgium., Marchant A; European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium.

Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2024 Nov; Vol. 43 (11), pp. 1857-1860. Date of Electronic Publication: 2024 Aug 10.

Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study.

Autor: Mukadi-Bamuleka D; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo; Rodolphe Mérieux Institut National de Recherche Biomédicale-Goma Laboratory, Goma, Democratic Republic of the Congo. Electronic address: drmukadi@gmail.com., Edidi-Atani F; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Morales-Betoulle ME; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Legand A; Health Emergencies Programme, WHO, Geneva, Switzerland., Nkuba-Ndaye A; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Bulabula-Penge J; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Mbala-Kingebeni P; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Crozier I; Clinical Monitoring Program Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mambu-Mbika F; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Whitmer S; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Tshiani Mbaya O; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Hensley LE; Zoonotic and Emerging Disease Research Unit, US Department of Agriculture National Bio and Agro-Defense Facility, Manhattan, KS, USA; National Institute for Allergy and Infectious Diseases-National Institutes of Health, Rockville, MD, USA., Kitenge-Omasumbu R; Programme Nationale d'Urgences et Actions Humanitaires, Ministry of Health, Kinshasa, Democratic Republic of the Congo., Davey R; National Institute for Allergy and Infectious Diseases-National Institutes of Health, Rockville, MD, USA., Mulangu S; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Fonjungo PN; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Wiley MR; University of Nebraska Medical Center, Omaha, NE, USA; PraesensBio, Omaha, NE, USA., Klena JD; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Peeters M; TransVIHMI, Université de Montpellier-IRD-INSERM, Montpellier, France., Delaporte E; TransVIHMI, Université de Montpellier-IRD-INSERM, Montpellier, France., van Griensven J; Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium., Ariën KK; Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium., Pratt C; University of Nebraska Medical Center, Omaha, NE, USA; Biosurv International, Salisbury, UK., Montgomery JM; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Formenty P; Health Emergencies Programme, WHO, Geneva, Switzerland., Muyembe-Tamfum JJ; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Ahuka-Mundeke S; Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service of Microbiology, Department of Medical Biology, Kinshasa University Hospital, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100905. Date of Electronic Publication: 2024 Sep 03.